Advanced search

Cabergoline in the treatment of hyperprolactinemia: A study in 455 patients.

Author
Organization

Citation

Please use this url to cite or link to this publication:

Chicago
VERHELST, J, R ABS, D MAITER, A VAN DEN BRUEL, Mark Vandeweghe, B VELKENIERS, J MOCKEL, et al. 1999. “Cabergoline in the Treatment of Hyperprolactinemia: A Study in 455 Patients.” Journal of Clinical Endocrinology and Metabolism 84 (7): 2518–2522.
APA
VERHELST, J, ABS, R., MAITER, D., VAN DEN BRUEL, A., Vandeweghe, M., VELKENIERS, B., MOCKEL, J., et al. (1999). Cabergoline in the treatment of hyperprolactinemia: A study in 455 patients. JOURNAL OF CLINICAL ENDOCRINOLOGY AND METABOLISM, 84(7), 2518–2522.
Vancouver
1.
VERHELST J, ABS R, MAITER D, VAN DEN BRUEL A, Vandeweghe M, VELKENIERS B, et al. Cabergoline in the treatment of hyperprolactinemia: A study in 455 patients. JOURNAL OF CLINICAL ENDOCRINOLOGY AND METABOLISM. 1999;84(7):2518–22.
MLA
VERHELST, J, R ABS, D MAITER, et al. “Cabergoline in the Treatment of Hyperprolactinemia: A Study in 455 Patients.” JOURNAL OF CLINICAL ENDOCRINOLOGY AND METABOLISM 84.7 (1999): 2518–2522. Print.
@article{114941,
  author       = {VERHELST, J and ABS, R and MAITER, D and VAN DEN BRUEL, A and Vandeweghe, Mark and VELKENIERS, B and MOCKEL, J and LAMBERIGTS, G and PETROSSIANS, P and COREMANS, P and MAHLER, C and STEVENAERT, A and VERLOOY, J and RAFTOPOULOS, C and BECKERS, A},
  issn         = {0021-972X},
  journal      = {JOURNAL OF CLINICAL ENDOCRINOLOGY AND METABOLISM},
  language     = {eng},
  number       = {7},
  pages        = {2518--2522},
  title        = {Cabergoline in the treatment of hyperprolactinemia: A study in 455 patients.},
  volume       = {84},
  year         = {1999},
}

Web of Science
Times cited: